AZB & Partners advised SK Capital to acquire Apotex, a global leader in affordable pharmaceuticals

An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) announced that it has reached an agreement to acquire Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”), a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines across all major therapeutic areas for patients around the world.

The team representing SK Capital comprised of Partners Ashwath Rau, Jasmin Karkhanis and Senior Associates Saras Muzumdar, Nitika Jain and Rashmee Kumar.

Write to us at deals@lawwiser.com